SCHEMBL754457

SCHEMBL754457

COC(=O)c1ccc(-c2ccc([C@H](C)[C@](O)(c3ccc(=O)n(C)c3)C(F)(F)F)c(Cl)c2)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.40
BAZ2B Q9UIF8 1/20 0.36
BAZ2A Q9UIF9 1/20 0.36
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 2/20 0.33
CFTR P13569 1/20 0.33
DPP4 P27487 2/20 0.33
DPP7 Q9UHL4 2/20 0.33
NR4A2 P43354 3/20 0.32
BDKRB1 P46663 1/20 0.32
P2RX3 P56373 1/20 0.32
MRGPRX4 Q96LA9 1/20 0.32
PDK1 Q15118 1/20 0.31
PDK3 Q15120 1/20 0.31
PDK4 Q16654 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
PKM P14618 1/20 0.31
F9 P00740 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL733268 1.00 PDK2 (0.40) PDK2BAZ2BBAZ2AKDM4ECYP1A2
SCHEMBL732326 0.94 KDM4E (0.36) PDK2BAZ2BBAZ2AKDM4ECFTR
SCHEMBL752282 0.94 KDM4E (0.36) PDK2BAZ2BBAZ2AKDM4ECFTR
SCHEMBL754904 0.93 PDK2 (0.36) PDK2BAZ2BBAZ2AKDM4ECFTR
SCHEMBL734838 0.93 PDK2 (0.36) PDK2BAZ2BBAZ2AKDM4ECFTR
SCHEMBL753039 0.91 SCN8A (0.34) PDK2BAZ2BBAZ2AKDM4ECYP1A2
SCHEMBL480093 0.91 SCN8A (0.34) PDK2BAZ2BBAZ2AKDM4ECYP1A2
SCHEMBL734223 0.90 PDK2 (0.36) PDK2BAZ2BBAZ2ADPP4DPP7
SCHEMBL755587 0.90 PDK2 (0.36) PDK2BAZ2BBAZ2ADPP4DPP7
SCHEMBL755590 0.86 ESR1 (0.35) KDM4ECYP2C19DPP4DPP7BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
WO-2010108902-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 PDK2 936/4885BAZ2B 4537/4885BAZ2A 4457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.